AI can do more than improve clinical supply forecasts. By connecting real-time signals, data, and human expertise, it can help teams spot risks sooner and act.
- Your IP Shipment Arrives At 07:00. Who Opens The Box?
- Segregation Of Duties: Drug Accountability Needs Three Separate Roles
- When Clinical Demand Becomes A Supply Plan
- Before The Excursion: The Governance Decisions That Should Already Be Made
- Clinical Trial Supply Chains Are Moving From Planning For Stability To Preparing For Uncertainty
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- The Silent Stockout: No One Owns The Data That Would Have Caught It
- Token Costs Will Decide Clinical Supply AI
ON-DEMAND WEBINARS
Early planning mitigates risk by avoiding stock outs and study delays, minimizing waste with optimized inventory, and forecasting demand to facilitate robust supply planning.
Individual data points over time can provide precise drug dosing histories that enable better understanding of protocol adherence, safety, efficacy, PK/PD and a drug’s exposure-response relationship.
This panel webinar discusses the importance of clinical supply agility and how to mitigate supply chain risk that comes along with clinical supply decisions.
Master clinical trial success by integrating IRT and RTSM through Quality by Design. Learn to proactively manage complexities, reduce operational risk, and ensure seamless global compliance.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1086011250 logistics, supply chain]( "Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led Solutions")
Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led SolutionsPharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.
-
![GettyImages-820427458 clinical trials]( "Ensure Seamless, Efficient Delivery Of Clinical Trial Materials Worldwide")
Ensure Seamless, Efficient Delivery Of Clinical Trial Materials WorldwideDrug discovery companies, CROs, and CDMOs are under pressure to find supply management solutions that ensure delivery of clinical trial materials while navigating complex study designs and the regulatory landscape.
-
![Vaccine injectable vials and syringe GettyImages-1252804942]( "Developing Injectable Drug Placebo Formulations For Clinical Trials")
Developing Injectable Drug Placebo Formulations For Clinical TrialsDeveloping a placebo for an injectable drug requires consideration of the formulation’s impact in trials, chemistry and physical details, ethical concerns, and regulatory compliance.
-
![GettyImages-1354932664 tech provider]( "Considerations When Selecting An Interactive Response Technology Provider")
Considerations When Selecting An Interactive Response Technology ProviderInteractive response technology (IRT) systems ensure clinical trial participants receive the correct treatment, facilitate enhanced logistics tracking, and empower users to obtain real-time data.
-
![iStock-1002126898-graph-tablet-meeting-risks-planning]( "Critical Requirements In Sourcing Comparator Drugs")
Critical Requirements In Sourcing Comparator DrugsSourcing comparator drugs has become complex in the clinical supply chain. As a result, clinical trial sponsors and pharma companies are eager to identify opportunities to overcome these challenges.
-
![GettyImages-2095813668-meeting-sustainability-screen-learning]( "Improving Site Efficiency With Automated Drug Resupply And Forecasting")
Improving Site Efficiency With Automated Drug Resupply And ForecastingInteractive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.
-
![GettyImages-1751848523-meeting-evaluation-charts-table]( "Writing Effective Clinical Regulatory Documents For Therapy Trials")
Writing Effective Clinical Regulatory Documents For Therapy TrialsClinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.
-
![patient clinical iStock-1174583087.jpg]( "How Clinical Trial Complexity Impacts End Users")
How Clinical Trial Complexity Impacts End UsersThis article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.
-
![GettyImages-1293773576-lab-team-collaboration-planning-research]( "Overcoming Inventory Challenges For A Complex, Global Study")
Overcoming Inventory Challenges For A Complex, Global StudyExplore how the optimization of Interactive Response Technologies (IRT) settings relieved the burden of managing global supply needs for a CRO customer and clinical sponsor.
-
![GettyImages-1293772957-scientist-laboratory-computer-drug-development]( "Five Key Trends In CMC")
Five Key Trends In CMCCMC is evolving with digitalization, sustainability, supply chain resilience, post-merger integration, and personalized medicine.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
